Chiron Capital Management’s Vivani Medical VANI Stock Holding History

Chiron Capital Management’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-435	Closed	-$1K	–	425
2020 Q3	$1K	Buy	+435	New	+$1.14K	﹤0.01%	485

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Chiron Capital Management's VANI Position: Q4 2020 in Review

Chiron Capital Management sold out of Vivani Medical (VANI) in Q4 2020, closing a stake of 435 shares — an estimated $1K sold.

Chiron Capital Management first reported a position in VANI in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 22 funds tracked by Wall St. Rank hold VANI as of Q4 2020.

Chiron Capital Management reported no remaining Vivani Medical position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 435 Vivani Medical shares in Q4 2020, an estimated $1K.
Chiron Capital Management first reported a position in Vivani Medical in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's Vivani Medical position peaked at $1K in Q3 2020.
22 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.